Semax in Canada

Semax is a synthetic ACTH(4-10) analogue (heptapeptide), and that classification is where the published work starts. The published work on it is in rat, human and mouse. Borealis Peptides supplies it as lyophilised powder in 10 mg vials and a ready-mixed nasal spray for in-vitro laboratory research. It is not authorized as a medicine and is not for use in any living subject. The studies behind it are listed on this page with the model each used and what the authors reported.

It ships within Canada from stock we hold, in 10 mg vials. Nothing leaves without HPLC confirmation of identity and purity for that batch. Borealis Peptides accepts research orders only, and ships to research and business addresses. Identity and purity are checked per batch, and the paperwork names that batch specifically.

No product containing Semax holds a Drug Identification Number in Canada. That means Health Canada has not assessed it for safety, efficacy or quality. Borealis Peptides holds it for in-vitro research; it is not supplied for use in any living subject. Health Canada has said that "Research Use Only" labelling does not make a product legal to use in a person, so we treat it as a description of what the material is supplied for rather than a permission. Lawful use in your own setting is yours to establish.

We do not answer dosing questions. Semax is not supplied for use in a person or an animal, so there is no dose to describe. What this page carries is the amount each cited study used and the model it used it in, reproduced as the authors published it.

Of the 8 studies cited, one is a controlled trial in people and the rest are animal or cell work. Each row names its model, the amount used and what the authors reported, so the weight of each study can be judged directly rather than through a summary.

Hold sealed vials at −20 °C, dry and dark. After mixing, storage is 2–8 °C. The lyophilised powder tolerates ambient temperature in transit, so it ships without ice and goes into the fridge on arrival. Repeated freeze-thaw cycles and light exposure are the real risks, not the shipping.

The nasal spray arrives as a finished solution in its own bottle, so nothing is added to it: no bacteriostatic water, no mixing, no transfer. Only the lyophilised vial is supplied dry, and that is the one format bacteriostatic water applies to. It is sold separately.

Every batch is tested by HPLC before it is sold, and the certificate refers to the batch in your vial rather than to the product in general. Keeping that batch number with your records is what makes an observation reproducible later. Certificates are available on request.

These are separate compounds with separate literatures; no ranking is offered here. Selank and DSIP have 8 cited studies and 8 cited studies on their page against 8 here. The useful comparison is between the two study tables and the models behind them.

Because it was among the peptides seized from sellers offering unauthorized injectable products online. The advisory concerns material sold for people to inject without authorization. Borealis Peptides supplies research material for laboratory use and sells nothing for injection or for any use in a person, which is the line that advisory draws.